Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level

2006 ◽  
Vol 42 (4) ◽  
pp. 456-459 ◽  
Author(s):  
Valérie Boige ◽  
Julien Taïeb ◽  
Mohamed Hebbar ◽  
David Malka ◽  
Thierry Debaere ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Dose Adjustment ◽  
Serum Bilirubin ◽  
Phase Ii Study ◽  
Serum Bilirubin Level ◽  
Advanced Hepatocellular Carcinoma ◽  
First Line ◽  
Baseline Serum ◽  
Multicenter Phase ◽  
Line Chemotherapy

scholarly journals Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study

Oncology ◽  
2013 ◽  
Vol 85 (1) ◽  
pp. 44-52 ◽  
Author(s):  
Chih-Hung Hsu ◽  
Yoon Koo Kang ◽  
Tsai-Shen Yang ◽  
Chia-Tung Shun ◽  
Yu-Yun Shao ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Hepatocellular Carcinoma ◽  
First Line ◽  
First Line Therapy ◽  
Asian Patients ◽  
Multicenter Phase ◽  
Line Therapy

Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study

2016 ◽  
Vol 77 (2) ◽  
pp. 243-250 ◽  
Author(s):  
Hiroaki Nagamatsu ◽  
Shuji Sumie ◽  
Takashi Niizeki ◽  
Nobuyoshi Tajiri ◽  
Hideki Iwamoto ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Hepatic Arterial Infusion ◽  
Advanced Hepatocellular Carcinoma ◽  
Arterial Infusion ◽  
Multicenter Phase

Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study

2009 ◽  
Vol 64 (4) ◽  
pp. 657-663 ◽  
Author(s):  
Jeeyun Lee ◽  
Kyung Hae Jung ◽  
Young Suk Park ◽  
Joong Bae Ahn ◽  
Sang Jun Shin ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
First Line ◽  
Multicenter Phase ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document